| 中國醫藥大學 |
2009-12-05 |
Relationship between MBD4 Polymorphism and Chinese Patients with Rheumatoid Arthritis in Taiwan
|
黃春明(Chung-Ming Huang); 陳俊宏(Jiunn-Horng Chen); 黃柏豪(Po-Hao Huang); 蔡輔仁(Fuu-Jen Tsai); 黃春明(Chung-Ming Huang) |
| 中國醫藥大學 |
2009-12 |
Limb-body wall complex in one fetus of a dizygotic twin pregnancy obtained by egg donation, in vitro fertilization and embryo transfer: prenatal diagnosis and literature review
|
陳持平(Chih-Ping Chen)*; (Maw-Shuan Lee); 蔡輔仁(Fuu-Jen Tsai); (Ming-Chao Huang); (Schu-Rern Chern); (Wayseen Wang) |
| 中國醫藥大學 |
2009-12 |
22q11.2 microdeletion in a fetus with double-outlet right ventricle, pulmonary stenosis and a ventricular septal defect by array comparative genomic hybridization
|
陳持平(Chih-Ping Chen)*; (Yi-Ning Su); (Tung-Yao Chang); (Schu-Rern Chern); 蔡輔仁(Fuu-Jen Tsai); (Jonathan Kwei Hwang); (Wayseen Wang) |
| 中國醫藥大學 |
2009-12 |
Trisomy 13 mosaicism associated with cyclopia and cystic hygroma
|
陳持平(Chih-Ping Chen)*; (Schu-Rern Chern); 蔡輔仁(Fuu-Jen Tsai); (Pei-Chen Wu); (Chen-Chi Lee); (Wayseen Wang) |
| 中國醫藥大學 |
2009-12 |
Down syndrome due to unbalanced homologous acrocentric rearrangements and its recurrence in subsequent pregnancies: prenatal diagnosis by amniocentesis
|
陳持平(Chih-Ping Chen)*; (Schu-Rern Chern); 蔡輔仁(Fuu-Jen Tsai); (Pei-Chen Wu); (Chen-Chi Lee); (Shu-Shien Chiang); (Wayseen Wang) |
| 中國醫藥大學 |
2009-12 |
Unbalanced and balanced acrocentric rearrangements involving chromosomes other than chromosome 21 at amniocentesis
|
陳持平(Chih-Ping Chen)*; (Schu-Rern Chern); (Pei-Chen Wu); 蔡輔仁(Fuu-Jen Tsai); (Chen-Chi Lee); (Dai-Dyi Town); (Wen-Lin Chen); (Li-Feng Chen); (Meng-Shan Lee); (Chen-Wen Pan); (Wayseen Wang) |
| 中國醫藥大學 |
2009-12 |
Genetic Variation in N-Methyl-D-Aspartate Receptor Subunit NR3A but Not NR3B Influences Susceptibility to Alzheimer's Disease
|
劉心萍(Hsin-Ping Liu); 林維勇(Wei-Yong Lin); (Shu-Hsiang Liu); (Wen-Fu Wang); 蔡崇豪(Chon-Haw Tsai); 吳柏蒼(Bor-Tsang Wu); (Chien-Kuo Wang); 蔡輔仁(Fuu-Jen Tsai)* |
| 中國醫藥大學 |
2009-12 |
RSC96 Schwann Cell Proliferation and Survival Induced by Dilong through PI3K/Akt Signaling Mediated by IGF-I
|
張永明(Yung-Ming Chang); (Wu-Hsien Kuo); 賴東淵(Tung-Yuan Lai); (Ying-Ting Shih); 蔡輔仁(Fuu-Jen Tsai); 蔡長海(Chang-Hai Tsai); (Wen-Tong Shu); (Ying-Yu Chen); 陳悅生(Yueh-Sheng Chen)*; 郭薇雯(Wei-Wen Kuo)*; 黃志揚(Chih-Yang Huang)* |
| 中國醫藥大學 |
2009-12 |
Rare Rearrangements: A ‘‘Jumping Satellite’’ in One Family and Autosomal Location of the SRY Gene in an XX Male
|
簡淑錦(Shu-Chin Chien); 李月君(Y.-C LI); 何銘(Ming- Ho); 許佩菁; 鄧如琇(Ru-Hsiou Teng); 林瑋德(Wei-De Lin); 蔡輔仁(Fuu-Jen Tsai)*; 林齊強(Chyi-Chyang Lin)* |
| 中國醫藥大學 |
2009-12 |
Pompe Disease in Infants: Improving the Prognosis by Newborn Screening and Early Treatment
|
蔡輔仁(Fuu-Jen Tsai);胡務亮* |
| 中國醫藥大學 |
2009-12 |
Prenatal diagnosis of terminal 2q deletion and distal 15q duplication by array comparative genomic hybridization using uncultured amniocytes
|
陳持平(Chih-Ping Chen)*; (Yi-Ning Su); 蔡輔仁(Fuu-Jen Tsai); (Hung-Hung Lin); (Schu-Rern Chern); (Meng-Shan Lee); (Jonathan Kwei Hwang); (Teresa Hsiao-Tien Chen); (Wayseen Wang) |
| 中國醫藥大學 |
2009-12 |
Levels of retinol-binding protein 4 and uric acid in patients with type 2 diabetes mellitus
|
陳清助(Ching-Chu Chen)*; 鄔哲源; 張淳堆(Chwen-Tzuei Chang); 蔡輔仁(Fuu-Jen Tsai); 王子源(Tzu-Yuan Wang); 劉怡敏(i-Min Liu); 崔懷芝(Huai-Chih Tsui); 陳榮興(Rong-Hsing Chen); 邱世欽(Shyh-Ching Chiou) |
| 中國醫藥大學 |
2009-12 |
Polymorphisms in the DNA repair gene XRCC1 and associations with systemic lupus erythematosus risk in the Taiwanese Han Chinese population.
|
林應如(Ying-Ju Lin); 萬磊(Lei Wan); 黃春明(Chung-Ming Huang); 陳世殷(Shih-Yin, Chen); 黃毓銓(Yu-Chuen Huang); 賴志河(Chih-Ho Lai); 林維勇(Wei-Yong Lin); 劉心萍(Hsin-Ping Liu); (Wu YS); 陳志玫(Chih-Mei Chen); 蔡育勳(Yuhsin Tsai); 蔡長海(Chang-Hai Tsai); 許晉銓(Jinn-Chyuan Sheu)*; 蔡輔仁(Fuu-Jen Tsai)* |
| 中國醫藥大學 |
2009-11-28 |
The Involvement of Insulin Receptor Genotypes in Pre- and Co-Obese Acanthosis Nigricans Children and Adolescent
|
包大(Da-Tian Bau)*; 王仲興(Chung-Hsing Wang); 林瑋德(Wei-De Lin); 周宜卿(I-Ching Chou); 王柔分(Rou-Fen Wang); 蔡佳紋(Chia-Wen Tsai); 蔡長海(Chang-Hai Tsai); 蔡輔仁(Fuu-Jen Tsai) |
| 中國醫藥大學 |
2009-11-28 |
Appearance of acanthosis nigricans may precede obesity: An involvement of insulin/IGF receptor signaling pathway
|
王仲興(Chung-Hsing Wang); 周宜卿(I-Ching Chou); 蔡長海(Chang-Hai Tsai); 林瑋德(Wei-De Lin); 王柔分(Rou-Fen Wang); 蔡佳紋(Chia-Wen Tsai); 蔡輔仁(Fuu-Jen Tsai); 包大(Da-Tian Bau)* |
| 中國醫藥大學 |
2009-11 |
Attenuated Cardiac Mitochondrial-dependent Apoptotic effects by Li-Fu Formula in hamsters fed with a hypercholesterol diet
|
郭薇雯(Wei-Wen Kuo); (Tsai-Ching Hsu); (Mei-Haung Chain); (Chao-Hung Lai); (Wen-Hong Wang); 蔡輔仁(Fuu-Jen Tsai); 蔡長海(Chang-Hai Tsai); (Chieh-His Wu)*; 黃志揚(Chih-Yang Huang)*; (Bor-Show Tzang)* |
| 中國醫藥大學 |
2009-11 |
Use of Electrical Stimulation at Different Current Levels to Promote Recovery After Peripheral Nerve Injury in Rats
|
呂明進(Ming-Chin Lu); 蔡金川(Chin-Chuan Tsai); (Shih-Che Chen); 蔡輔仁(Fuu-Jen Tsai); 姚俊旭(Chun-Hsu Yao)*; 陳悅生(Yueh-Sheng Chen)* |
| 中國醫藥大學 |
2009-11 |
A Novel Genetic Variant of BMP2K Contributes to High Myopia
|
劉心萍(Hsin-Ping Liu); 林應如(Ying-Ju Lin); 林維勇(Wei-Yong Lin); 萬磊(Lei Wan); 許晉銓(Jinn-Chyuan Sheu); 林慧茹(Hui-Ju Lin); 蔡育勳(Yuhsin Tsai); 蔡長海(Chang-Hai Tsai); 蔡輔仁(Fuu-Jen Tsai)* |
| 中國醫藥大學 |
2009-11 |
Uncaria rhyncholylla up-regulates the expression of MIF and cyclophilin A in Kainic acid-induced epilepsy rats: a proteomic analysis
|
羅婉瑜(Wan-Yu Lo); 蔡輔仁(Fuu-Jen Tsai); 劉崇祥(Chung-Hsiang Liu); 唐娜櫻(Nou-Ying Tang); 蘇珊玉(Shan-Yu Su); 林欣榮(Shinn-Zong Lin); 陳春忠(CHUN-CHUNG CHEN); 徐偉成(Woei-Cherng Shyu); 謝慶良(Ching-Liang Hsieh)* |
| 中國醫藥大學 |
2009-10-20 |
Ligand-based design for heat shock protein 90 inhibitors
|
陳語謙(Chen, Calvin Yu-Chian); 蔡輔仁(Fuu-Jen Tsai); 蔡長海(Chang-Hai Tsai); 陳語謙(Chen, Calvin Yu-Chian) |
| 中國醫藥大學 |
2009-10-20 |
Discovery the triple inhibitors of H5N1, H5N2, and H5N7 by pharmacophore analysis
|
(Chien-Yu Chen); 陳語謙(Chen, Calvin Yu-Chian)*; 蔡輔仁(Fuu-Jen Tsai); 蔡長海(Chang-Hai Tsai); 包大?(Da-Tian Bau); 陳語謙(Chen, Calvin Yu-Chian) |
| 中國醫藥大學 |
2009-10-17 |
A Novel Strategy for Designing Dual-target Inhibitors of KU86 and XRCC4
|
陳建宇(Chien-Yu Chen); 蔡輔仁(Fuu-Jen Tsai); 鍾景光(Jing-Gung Chung); 蔡長海(Chang-Hai Tsai); 徐媛曼(Yuan-Man Hsu); 黃泓縉(Hung-Jin Huang); 侯庭鏞(Tin-Yun Ho); (Yea-Huey Chang); 包大?(Da-Tian Bau); 蔡銘修(Ming-Hsui Tsai); 陳語謙(Chen, Calvin Yu-Chian) |
| 中國醫藥大學 |
2009-10-17 |
Reducing without Side Effects? A Novel Strategy for Designing the PPAR Agonists
|
(Yea-Huey Chang); 包大?(Da-Tian Bau); 蔡銘修(Ming-Hsui Tsai); 徐媛曼(Yuan-Man Hsu); 侯庭鏞(Tin-Yun Ho); 陳建宇(Chien-Yu Chen); (Hung-Jin Huang); 蔡輔仁(Fuu-Jen Tsai); 蔡長海(Chang-Hai Tsai); 陳語謙(Chen, Calvin Yu-Chian)* |
| 中國醫藥大學 |
2009-10-17 |
Is That Possible to Design the Versatile Inhibitors for H1N1, H5N1, H5N2, and H5N7 ?
|
陳建宇(Chien-Yu Chen); 包大?(Da-Tian Bau); 蔡銘修(Ming-Hsui Tsai); 徐媛曼(Yuan-Man Hsu); 侯庭鏞(Tin-Yun Ho); 黃泓縉(Hung-Jin Huang); (Yea-Huey Chang); 蔡輔仁(Fuu-Jen Tsai); 蔡長海(Chang-Hai Tsai); 陳語謙(Chen, Calvin Yu-Chian)* |
| 中國醫藥大學 |
2009-10-17 |
Could Traditional Chinese Medicine Used for Curing Erectile Dysfunction
|
陳建宇(Chien-Yu Chen); 包大?(Da-Tian Bau); 蔡銘修(Ming-Hsui Tsai); 徐媛曼(Yuan-Man Hsu); 侯庭鏞(Tin-Yun Ho); 黃泓縉(Hung-Jin Huang); (Yea-Huey Chang); 蔡輔仁(Fuu-Jen Tsai); 蔡長海(Chang-Hai Tsai); 陳語謙(Chen, Calvin Yu-Chian)* |
| 中國醫藥大學 |
2009-10-17 |
Drug Design for KU86 in DNA Break Repair System
|
陳建宇(Chien-Yu Chen); 包大?(Da-Tian Bau); 蔡銘修(Ming-Hsui Tsai); 徐媛曼(Yuan-Man Hsu); 侯庭鏞(Tin-Yun Ho); 黃泓縉(Hung-Jin Huang); (Yea-Huey Chang); 蔡輔仁(Fuu-Jen Tsai); 蔡長海(Chang-Hai Tsai); 陳語謙(Chen, Calvin Yu-Chian)* |
| 中國醫藥大學 |
2009-10-17 |
Dual-targeted Drug Design of HER2 and HSP90 by CoMFA Model and Pharmacophore Analysis
|
黃泓縉(Hung-Jin Huang); 包大?(Da-Tian Bau); 蔡銘修(Ming-Hsui Tsai); 徐媛曼(Yuan-Man Hsu); 侯庭鏞(Tin-Yun Ho); 陳建宇(Chien-Yu Chen); (Yea-Huey Chang); 蔡輔仁(Fuu-Jen Tsai); 蔡長海(Chang-Hai Tsai); 陳語謙(Chen, Calvin Yu-Chian)* |
| 中國醫藥大學 |
2009-10-17 |
Drug Design for AMP-Activated Protein Kinase Agonists in Silico
|
陳建宇(Chien-Yu Chen); 包大?(Da-Tian Bau); 蔡銘修(Ming-Hsui Tsai); 徐媛曼(Yuan-Man Hsu); 侯庭鏞(Tin-Yun Ho); 黃泓縉(Hung-Jin Huang); (Yea-Huey Chang); 蔡輔仁(Fuu-Jen Tsai); 蔡長海(Chang-Hai Tsai); 陳語謙(Chen, Calvin Yu-Chian)* |
| 中國醫藥大學 |
2009-10-17 |
Reducing without Side Effects A Novel Strategy for Designing the PPAR Agonists
|
(Yea-Huey Chang); (Bau Da Tien); 蔡銘修(Ming-Hsui Tsai); 徐媛曼(Yuan-Man Hsu); 侯庭鏞(Tin-Yun Ho); 陳建宇(Chien-Yu Chen); (Hung-Jin Huang); 蔡輔仁(Fuu-Jen Tsai); 蔡長海(Chang-Hai Tsai); 陳語謙(Calvin Yu-Chian Chen)* |
| 中國醫藥大學 |
2009-10-17 |
Drug Design for the Influenza A Virus Subtype H1N1
|
陳建宇(Chien-Yu Chen); 蔡輔仁(Fuu-Jen Tsai); 鍾景光(Jing-Gung Chung); 蔡長海(Chang-Hai Tsai); 徐媛曼(Yuan-Man Hsu); 黃泓縉(Hung-Jin Huang); 侯庭鏞(Tin-Yun Ho); (Yea-Huey Chang); 包大?(Da-Tian Bau); 蔡銘修(Ming-Hsui Tsai); 陳語謙(Chen, Calvin Yu-Chian) |
| 中國醫藥大學 |
2009-10-17 |
Drug Design for XRCC4 in Silico
|
黃泓縉(Hung-Jin Huang); 蔡輔仁(Fuu-Jen Tsai); 鍾景光(Jing-Gung Chung); 蔡長海(Chang-Hai Tsai); 徐媛曼(Yuan-Man Hsu); 侯庭鏞(Tin-Yun Ho); (Yea-Huey Chang); 包大?(Da-Tian Bau); 蔡銘修(Ming-Hsui Tsai); 陳語謙(Chen, Calvin Yu-Chian)* |
| 中國醫藥大學 |
2009-10-17 |
What is the Key Point for Designing HER2 Inhibitors
|
黃泓縉(Hung-Jin Huang); 包大?(Da-Tian Bau); 蔡銘修(Ming-Hsui Tsai); 徐媛曼(Yuan-Man Hsu); 侯庭鏞(Tin-Yun Ho); 陳建宇(Chien-Yu Chen); (Yea-Huey Chang); 蔡輔仁(Fuu-Jen Tsai); 蔡長海(Chang-Hai Tsai); 陳語謙(Chen, Calvin Yu-Chian)* |
| 中國醫藥大學 |
2009-10-09 |
Fabrication of multi-functional SiO2@Au core-shell nanoparticles
|
(Chien-Yu Chen); (Yea-Huey Chang); 蔡輔仁(Fuu-Jen Tsai); 蔡長海(Chang-Hai Tsai); 陳語謙(Chen, Calvin Yu-Chian); 陳語謙(Chen, Calvin Yu-Chian); 陳語謙(Chen, Calvin Yu-Chian) |
| 中國醫藥大學 |
2009-10-09 |
Discovery of the AMP-activated protein kinase agonists by molecular docking and 3D-QSAR analysis
|
陳建宇(Chien-Yu Chen); (Yea-Huey Chang); 蔡輔仁(Fuu-Jen Tsai); 蔡長海(Chang-Hai Tsai); 陳語謙(Chen, Calvin Yu-Chian)*; 陳建宇(Chien-Yu Chen); 陳語謙(Chen, Calvin Yu-Chian) |
| 中國醫藥大學 |
2009-10 |
Fabrication of SiO2@Au Core-Shell Multi-functional Nanoparticles (MFNPs) for Imaging and Thermotherapy
|
(Yea-Huey Chang); 包大靝(Da-Tian Bau); 李英雄(Ying-shiung Lee); 陳建宇(Chien-Yu Chen); 黃泓縉(Hung-Jin Huang); 蔡輔仁(Fuu-Jen Tsai)*; 蔡長海(Chang-Hai Tsai)*; 陳語謙(Chen, Calvin Yu-Chian)* |
| 中國醫藥大學 |
2009-10 |
Study of AMP-activated Protein Kinase Agonists by Structure-based Drug Designing
|
(Yea-Huey Chang); 侯庭鏞(Tin-Yun Ho); 吳介信(Chieh-Hsi Wu); 陳建宇(Chien-Yu Chen); 黃泓溍(Hung-Jin Huang); 蔡輔仁(Fuu-Jen Tsai)*; 蔡長海(Chang-Hai Tsai); 陳語謙(Chen, Calvin Yu-Chian)* |
| 中國醫藥大學 |
2009-10 |
Discovery the inhibitors of H5N1, H5N2, and H5N7 by pharmacophore analysis
|
陳建宇(Chien-yu CHEN); (Yea-huey CHANG); 包大靝(Da-Tian Bau); 黃泓縉(Hung-jin HUANG); 蔡輔仁(Fuu-Jen Tsai)*; 蔡長海(Chang-Hai Tsai)*; 陳語謙(Chen, Calvin Yu-Chian)* |
| 中國醫藥大學 |
2009-10 |
Is That Possible to Design the Versatile Inhibitors for H1N1, H5N1, H5N2, and H5N7
|
陳建宇(Chien-Yu Chen); 包大靝(Da-Tian Bau); 蔡銘修(Ming-Hsui Tsai); 徐媛曼(Yuan-Man Hsu); 侯庭鏞(Tin-Yun Ho); 黃泓縉(Hung-Jin Huang); (Yea-Huey Chang); 蔡輔仁(Fuu-Jen Tsai)*; 蔡長海(Chang-Hai Tsai)*; 陳語謙(Chen, Calvin Yu-Chian)* |
| 中國醫藥大學 |
2009-10 |
Drug Design for the Influenza A Virus Subtype H1N1
|
陳建宇(Chien-Yu Chen); 包大靝(Da-Tian Bau); 蔡銘修(Ming-Hsui Tsai); 徐媛曼(Yuan-Man Hsu); 侯庭鏞(Tin-Yun Ho); 黃泓縉(Hung-Jin Huang); (Yea-Huey Chang); 蔡輔仁(Fuu-Jen Tsai)*; 蔡長海(Chang-Hai Tsai)*; 陳語謙(Chen, Calvin Yu-Chian)* |
| 中國醫藥大學 |
2009-10 |
Drug Design for KU86 in DNA Break Repair System
|
陳建宇(Chien-Yu Chen); 包大靝(Da-Tian Bau); 蔡銘修(Ming-Hsui Tsai); 徐媛曼(Yuan-Man Hsu); 侯庭鏞(Tin-Yun Ho); 黃泓縉(Hung-Jin Huang); (Yea-Huey Chang); 蔡輔仁(Fuu-Jen Tsai)*; 蔡長海(Chang-Hai Tsai)*; 陳語謙(Chen, Calvin Yu-Chian)* |
| 中國醫藥大學 |
2009-10 |
A Novel Strategy for Designing Dual-target Inhibitors of KU86 and XRCC4
|
陳建宇(Chien-Yu Chen); 蔡輔仁(Fuu-Jen Tsai); 鍾景光(Jing-Gung Chung); 蔡長海(Chang-Hai Tsai); 徐媛曼(Yuan-Man Hsu); 黃泓縉(Hung-Jin Huang); 侯庭鏞(Tin-Yun Ho); (Yea-Huey Chang); 包大靝(Da-Tian Bau)*; 蔡銘修(Ming-Hsui Tsai)*; 陳語謙(Chen, Calvin Yu-Chian)* |
| 中國醫藥大學 |
2009-10 |
Drug Design for AMP-Activated Protein Kinase Agonists in Silico
|
陳建宇(Chien-Yu Chen); 包大靝(Da-Tian Bau); 蔡銘修(Ming-Hsui Tsai); 徐媛曼(Yuan-Man Hsu); 侯庭鏞(Tin-Yun Ho); 黃泓縉(Hung-Jin Huang); (Yea-Huey Chang); 蔡輔仁(Fuu-Jen Tsai)*; 蔡長海(Chang-Hai Tsai)*; 陳語謙(Chen, Calvin Yu-Chian)* |
| 中國醫藥大學 |
2009-10 |
Could Traditional Chinese Medicine Used for Curing Erectile Dysfunction
|
陳建宇(Chien-Yu Chen);包大靝(Da-Tian Bau);蔡銘修(Ming-Hsui Tsai);徐媛曼(Yuan-Man Hsu);侯庭鏞(Tin-Yun Ho);黃泓縉(Hung-Jin Huang);(Yea-Huey Chang);蔡輔仁(Fuu-Jen Tsai)*;蔡長海(Chang-Hai Tsai)*;陳語謙(Chen, Calvin Yu-Chian)* |
| 中國醫藥大學 |
2009-10 |
Ligand-Based Dual Target Drug Design for H1N1: Swine Flu- A Preliminary First Study
|
陳建宇(Chien-Yu Chen); (Yea-Huey Chang); 包大靝(Da-Tian Bau); (Hung-Jin Huang); 蔡輔仁(Fuu-Jen Tsai)*; 蔡長海(Chang-Hai Tsai)*; 陳語謙(Chen, Calvin Yu-Chian)* |
| 中國醫藥大學 |
2009-10 |
Drug design for Influenza A virus subtype H1N1
|
陳建宇(Chien-Yu Chen);包大靝(Da-Tian Bau);(Yea-Huey Chang);徐媛曼(Yuan-Man Hsu);侯庭鏞(Tin-Yun Ho);黃泓縉(Hung-Jin Huang);蔡輔仁(Fuu-Jen Tsai)*;蔡長海(Chang-Hai Tsai)*;陳語謙(Chen, Calvin Yu-Chian)*;(Yu-An Chang) |
| 中國醫藥大學 |
2009-10 |
Preliminary study of ethylene glycol-induced alanine-glyoxylate aminotransferase 2 expression in rat kidney
|
陳汶吉(Chen, Wen-Chi); 劉心萍(Hsin-Ping Liu); 吳錫金(Wu,Hsi-Chin); (Chou-Huang Tsai); 陳慧毅(Huey-Yi Chen); 陳幸宜(Hsin-Yi Chen); 蔡輔仁(Fuu-Jen Tsai); (Chiao-Hui Chang); (Po-Len Liu); (Feng-Yen Line); (Yi-Chun Chang); 林維勇(Wei-Yong Lin); 陳永祥(Yung-Hsiang Chen)* |
| 中國醫藥大學 |
2009-10 |
Ligand-based design for heat shock protein 90 inhibitors
|
黃泓縉(Hung-Jin Huang); 陳建宇(Chien-Yu Chen); (Yea-Huey Chang); 蔡輔仁(Fuu-Jen Tsai); 陳語謙(Chen, Calvin Yu-Chian)* |
| 中國醫藥大學 |
2009-10 |
Ligand-Based Dual Target Drug Design for H1N1: Swine Flu- A Preliminary First Study
|
陳建宇(Chien-Yu Chen); (Yea-Huey Chang); (Bau Da Tian); 黃泓溍(Hung-Jin Huang); 蔡輔仁(Fuu-Jen Tsai); 蔡長海(Chang-Hai Tsai); 陳語謙(Calvin Yu-Chian Chen)* |
| 中國醫藥大學 |
2009-10 |
Is That Possible to Design the Versatile Inhibitors for H1N1, H5N1, H5N2, and H5N7
|
陳建宇(Chien-Yu Chen); (Bau Da Tien); 蔡銘修(Ming-Hsui Tsai); 徐媛曼(Yuan-Man Hsu); 侯庭鏞(Tin-Yun Ho); 黃泓縉(Hung-Jin Huang); (Yea-Huey Chang); 蔡輔仁(Fuu-Jen Tsai); 蔡長海(Chang-Hai Tsai); 陳語謙(Calvin Yu-Chian Chen)* |
| 中國醫藥大學 |
2009-10 |
Drug Design for the Influenza A Virus Subtype H1N1
|
陳建宇(Chien-Yu Chen); (Bau Da Tien); 蔡銘修(Ming-Hsui Tsai); 徐媛曼(Yuan-Man Hsu); 侯庭鏞(Tin-Yun Ho); 黃泓縉(Hung-Jin Huang); (Yea-Huey Chang); 蔡輔仁(Fuu-Jen Tsai); 蔡長海(Chang-Hai Tsai); 陳語謙(Calvin Yu-Chian Chen)* |
